NEEDHAM, Mass.--(BUSINESS WIRE)--Una. S. Ryan, Ph.D., President and Chief Executive Officer of AVANT Immunotherapeutics (Nasdaq: AVAN) was awarded the Albert Einstein Award, presented in Jerusalem June 25 during the 18th International Networking and Gala Awards Mission to Israel and Jordan by Global Capital Associates’ Global Business Leadership Council. Dr. Ryan was honored for her leadership in the development of new vaccines for serious global infectious diseases including cholera, ETEC, typhoid, paratyphoid and rotavirus disease and for her leadership in the biotechnology industry.
